paris/инсульт

Ссылка сохраняется в буфер обмена

Выберите тип сортировки

Страница 1 от 82 полученные результаты

[Medical treatment abroad. Why Bjørnstjerne Bjørnson died in Paris 1910].

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

The Norwegian poet and playwright Bjørnstjerne Bjørnson (1832-1910), Nobel prize laureate in literature 1903, died in Paris. He had suffered from angina pectoris for a few years and had difficulties in walking because of thrombophlebitis in his right leg. In 1909, he had received electrotherapy from

Treatment of Acute Ischemic Stroke Due to Large Vessel Occlusion With COVID-19: Experience From Paris

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

Background and purpose: Higher rates of strokes have been observed in patients with coronavirus disease 2019 (COVID-19), but data regarding the outcomes of COVID-19 patients suffering from acute ischemic stroke due to large vessel occlusion (LVO) are lacking. We

[Neurology in Paris hospitals, particularly the Salpêtrière before Charcot: Rostan on brain softening].

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

In the beginning of the 19th century, many studies were devoted to the diseases of the nervous system in France, long before the work of Charcot. The researches of Léon Rostan on the cerebral softening (1819, 1823) were based on the anatomoclinic method developed by the School of Paris whose most

Air pollution and humidity as triggering factors for stroke. Results of a 12-year analysis in the West Paris area.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

Previous studies have suggested an association between stroke and meteorological factors, air pollution and acute respiratory infections as triggering factors. Often, these factors have been evaluated separately. We evaluated the association between all these environmental triggering

Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

The Patterns of non-Adherence to Anti-Platelet Regimen in Stented Patients (PARIS) thrombotic risk score is a novel score for predicting the risk of coronary thrombotic events after percutaneous coronary intervention (PCI). We assessed the prognostic value of this score for mortality in patients

[Effect of August 2003 heat wave in France on a hospital biochemistry laboratory activity in Paris].

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

In August 2003, France sustained an exceptional heat wave. Heat-generated pathologies (dehydratation, heat stroke, cardio-vascular diseases) were responsible for additional biological analysis orders at the Saint-Antoine Hospital biochemistry laboratory in Paris from 4 to 18 august, compared to the

Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

OBJECTIVE Shock is a severe syndrome resulting in multiple organ dysfunction and a high mortality rate. The goal of this consensus statement is to provide recommendations regarding the monitoring and management of the critically ill patient with shock. METHODS An international consensus conference

Paris Prospective Study III: a study of novel heart rate parameters, baroreflex sensitivity and risk of sudden death.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

Resting heart rate has been related to the risk of cardiovascular disease and sudden death in several large prospective studies. To investigate prospectively the association of novel heart rate parameters and of carotid artery stiffness with sudden death and other cardiovascular disease. The Paris

Major bleeding complications in patients treated with direct oral anticoagulants: One-year observational study in a Paris Hospital.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

Direct oral anticoagulants (DAOC) are indicated for the treatment of venous thromboembolism and the prevention of stroke or systemic embolism in patients with non-valvular atrial fibrillation. Given their advantages and friendly use for patient, the prescription of long term DOAC therapy has rapidly

Update in Neurocritical Care: a summary of the 2018 Paris international conference of the French Society of Intensive Care.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

The 2018 Paris Intensive Care symposium entitled "Update in Neurocritical Care" was organized in Paris, June 21-22, 2018, under the auspices of the French Intensive Care Society. This 2-day post-graduate educational symposium comprised several chapters, aiming first to provide all-board

Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University Hospitals.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

Despite the increasing and broadening use of agents targeting the vascular endothelial growth factor (VEGF) pathway, little is known on their acute neurovascular toxicities. This retrospective, multi-centre study examined the characteristics of patients with solid tumours who experienced an

Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

We conducted a retrospective study on newborns with sickle-cell disease (SCD), born 1995-2009, followed in a multicentre hospital-based network. We assessed patient outcomes, medical care and compliance with the national guidelines published in December 2005. Data from 1033 patients (742

Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry).

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

The impact of dual antiplatelet therapy (DAPT) cessation after percutaneous coronary intervention with drug eluting stent implantation in patients at high atherothrombotic risk remains unclear. We aimed to characterize the risk for adverse events, and its relation with the mode of DAPT cessation in

Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysis

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

Aims: Limited data exist regarding the incidence and aetiology of life-threatening events such as major cardiac events or exertional heat stroke during long-distance races. We aimed to provide an updated incidence, etiology and prognosis

Stroke associated with pulmonary embolism after air travel.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

Prolonged air travel is associated with an increased incidence of thromboembolic events. The occurrence of stroke was studied in patients with pulmonary embolism after air travel in a review of all flights arriving at Charles de Gaulle Airport in Paris during an 8-year period. Thromboembolic stroke

Присоединяйтесь к нашей
странице facebook

Herbal & Natural Medicine

Самая полная база данных о лекарственных травах, подтвержденная наукой

Работает на 55 языках
Травяные лекарства, подтвержденные наукой
Распознавание трав по изображению
Интерактивная карта GPS - отметьте травы на месте (скоро)
Прочтите научные публикации, связанные с вашим поиском
Ищите лекарственные травы по их действию
Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов

Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.